HPV testing in primary screening of older women
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Certain types of the human papilloma virus (HPV) are well established as the primary cause of cervical cancer. Several studies have shown that HPV testing can improve the detection rate of high-grade cervical intraepithelial neoplasia (CIN), but these have been carried out primarily in younger women. In this study we evaluated the role of HPV testing as an adjunct to cytology in women aged 35 or over. An additional aim was to evaluate commercially available kits for HPV testing. A total of 2988 eligible women aged 34 or more attending for a routine smear in 40 general practitioner practices received HPV testing in addition to routine cytology, after having given written informed consent. Samples were assayed by polymerase chain reaction (PCR) and two versions of the Hybrid Capture test for HPV, and women were invited for colposcopy if there was any cytological abnormality (including borderline smears) or the PCR test was positive. Any apparent abnormality was biopsied and loop-excision was performed as necessary. CIN was judged by histology; 42 women had high-grade CIN, of which six were cytology negative (86% sensitivity for borderline or worse) and three had a borderline smear (79% sensitivity for mild dyskaryosis or worse). The positive predictive value of a borderline smear was only 3.1%. Eleven high-grade lesions were negative by the PCR HPV test (sensitivity 74%). The first generation Hybrid Capture II test had a similar sensitivity but an unacceptably high false positive rate (18.3%), while the newer Hybrid Capture II microtitre kit had a 95% sensitivity and a 2.3% positivity rate in normal women when used at a 2 pg ml(-1) cut-off (positive predictive value 27%). Cytology performed very well in this older cohort of women. The newer Hybrid Capture II microtitre test may be a useful adjunct, especially if the results reported here are reproducible in other studies. A combined screening test offers the possibility of greater protection and/or longer screening intervals, which could reduce the overall cost of the screening programme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia
Ho, G. Y. F., Burk, R. D., Klein, S., Kadish, A. S., Chang, C. J., Palan, P., Basu, J., Tachezy, R., Lewis, R., & Romney, S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.18.1365 · Cited by 803
Persistence of Type-Specific Human Papillomavirus Infection among Cytologically Normal Women
Hildesheim, A., Schiffman, M. H., Gravitt, P. E., Glass, A. G., Greer, C. E., Zhang, T., Scott, D. R., Rush, B. B., Lawler, P., Sherman, M. E., et al. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.2.235 · Cited by 682
Cox, J. T., Lorincz, A. T., Schiffman, M. H., Sherman, M. E., Cullen, A., & Kurman, R. J. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90026-8 · Cited by 417
Self-citationHuman papillomavirus testing in primary cervical screening
Cuzick, J., Szarewski, A., Terry, G., Hanby, A., Maddox, P., Anderson, M., Steele, S. J., Guillebaud, J., & Kocjean, C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91086-7 · Cited by 328
Self-citationKinney, W. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00080-5 · Cited by 274
Londesborough, P., Ho, L., Terry, G., Cuzick, J., Wheeler, C., & Singer, A. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961021)69:5<364::aid-ijc2>3.0.co;2-3 · Cited by 224
Self-citationLondesborough, P., Ho, L., Terry, G., Cuzick, J. M., Wheeler, C. M., & Singer, A. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961021)69:5<364::aid-ijc2>3.3.co;2-u · Cited by 224
Self-citationCuzick, J., Terry, G., Ho, L., Hollingworth, T., & Anderson, M. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.28 · Cited by 187
Self-citationNew developments in cervical cancer screening and prevention
Franco, E. L., & Monsonégo, J. (1997) · Cited by 177
Should patients with mild atypia in a cervical smear be referred for colposcopy?
SOUTTER, W. P., WISDOM, S., BROUGH, A. K., & MONAGHAN, J. M. (1986) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1986.tb07816.x · Cited by 173
Cited by
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
Self-citationde Sanjosé, S., Diaz, M., Castellsagué, X., Clifford, G., Bruni, L., Muñoz, N., & Bosch, F. X. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70158-5 · Cited by 1,669
Cuzick, J., Clavel, C., Petry, K., Meijer, C. J. L. M., Hoyer, H., Ratnam, S., Szarewski, A., Birembaut, P., Kulasingam, S., Sasieni, P., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21955 · Cited by 1,141
Self-citationHuman Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer
Mayrand, M.-H., Duarte-Franco, E., Rodrigues, I., Walter, S. D., Hanley, J., Ferenczy, A., Ratnam, S., Coutlée, F., & Franco, E. L. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071430 · Cited by 1,100
American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer
Saslow, D., Runowicz, C. D., Solomon, D., Moscicki, A.-B., Smith, R. A., Eyre, H. J., & Cohen, C. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.342 · Cited by 927
Chapter 1: Human Papillomavirus and Cervical Cancer--Burden and Assessment of Causality
Bosch, F. X., & de Sanjose, S. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003479 · Cited by 826
Management of women who test positive for high-risk types of human papillomavirus: the HART study
Cuzick, J., Szarewski, A., Cubie, H., Hulman, G., Kitchener, H., Luesley, D., McGoogan, E., Menon, U., Terry, G., Edwards, R., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14955-0 · Cited by 510
Self-citationCytology versus HPV testing for cervical cancer screening in the general population
Koliopoulos, G., Nyaga, V. N., Santesso, N., Bryant, A., Martin-Hirsch, P. P., Mustafa, R. A., Schünemann, H., Paraskevaidis, E., & Arbyn, M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008587.pub2 · Cited by 494
Clavel, C., Masure, M., Bory, J.-P., Putaud, I., Mangeonjean, C., Lorenzato, M., Nazeyrollas, P., Gabriel, R., Quereux, C., & Birembaut, P. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1845 · Cited by 465
Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection.
(2001) · Europe PMC (PubMed Central) · Cited by 463
Kulasingam, S. L., Hughes, J. P., Kiviat, N. B., Mao, C., Weiss, N. S., Kuypers, J. M., & Koutsky, L. A. (2002) · JAMA · doi:10.1001/jama.288.14.1749 · Cited by 452
Sherman, M. E., Lorincz, A. T., Scott, D. R., Wacholder, S., Castle, P. E., Glass, A. G., Mielzynska-Lohnas, I., Rush, B. B., & Schiffman, M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.46 · Cited by 430
Self-citationAge-Specific Prevalence of Infection with Human Papillomavirus in Females: A Global Review
Smith, J. S., Melendy, A., Rana, R. K., & Pimenta, J. M. (2008) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2008.07.009 · Cited by 377
Goldie, S. J., Kuhn, L., Denny, L., Pollack, A., & Wright, T. C. (2001) · JAMA · doi:10.1001/jama.285.24.3107 · Cited by 335
Epidemiology of HPV infection among Mexican women with normal cervical cytology
Lazcano‐Ponce, E., Herrero, R., Muñoz, N., Cruz, A., Shah, K. V., Alonso, P., Hernández, P., Salmerón, J., & Hernández, M. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010201)91:3<412::aid-ijc1071>3.0.co;2-m · Cited by 324
Recent trends in the epidemiology of sexually transmitted infections in the European Union
Fenton, K. A. (2004) · Sexually Transmitted Infections · doi:10.1136/sti.2004.009415 · Cited by 323
Sankaranarayanan, R., Basu, P., Wesley, R. S., Mahe, C., Keita, N., Mbalawa, C. C. G., Sharma, R., Dolo, A., Shastri, S. S., Nacoulma, M., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20190 · Cited by 319
Ronco, G., Segnan, N., Giorgi-Rossi, P., Zappa, M., Casadei, G. P., Carozzi, F., Palma, P. D., Del Mistro, A., Folicaldi, S., Gillio-Tos, A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj209 · Cited by 313
Self-citationBenefits and Costs of Using HPV Testing to Screen for Cervical Cancer
Mandelblatt, J. S. (2002) · JAMA · doi:10.1001/jama.287.18.2372 · Cited by 308
Ronco, G., Giorgi-Rossi, P., Carozzi, F., Confortini, M., Palma, P. D., Del Mistro, A., Gillio-Tos, A., Minucci, D., Naldoni, C., Rizzolo, R., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn065 · Cited by 306
Self-citationPetry, K.-U., Menton, S., Menton, M., van Loenen-Frosch, F., de Carvalho Gomes, H., Holz, B., Schopp, B., Garbrecht-Buettner, S., Davies, P., Boehmer, G., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600918 · Cited by 300
Ogilvie, G. S., van Niekerk, D., Krajden, M., Smith, L. W., Cook, D., Gondara, L., Ceballos, K., Quinlan, D., Lee, M., Martin, R. E., et al. (2018) · JAMA · doi:10.1001/jama.2018.7464 · Cited by 279
Sherman, M. E., Schiffman, M., & Cox, J. T. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.2.102 · Cited by 270
Bulkmans, N. W. J., Rozendaal, L., Snijders, P. J. F., Voorhorst, F. J., Boeke, A. J. P., Zandwijken, G. R. J., van Kemenade, F. J., Verheijen, R. H. M., v Groningen, K., Boon, M. E., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20076 · Cited by 269
Cuschieri, K. S., Cubie, H. A., Whitley, M. W., Seagar, A. L., Arends, M. J., Moore, C., Gilkisson, G., & McGoogan, E. (2004) · Journal of Clinical Pathology · doi:10.1136/jcp.57.1.68 · Cited by 267
Prevalence and determinants of HPV infection among Colombian women with normal cytology
the HPV Study Group HPV Study, Molano, M., Posso, H., Weiderpass, E., van den Brule, A. J. C., Ronderos, M., Franceschi, S., Meijer, C. J. L. M., Arslan, A., & Munoz, N. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600442 · Cited by 263
Koliopoulos, G., Arbyn, M., Martin-Hirsch, P., Kyrgiou, M., Prendiville, W., & Paraskevaidis, E. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.08.053 · Cited by 254
Chapter 13: Primary Screening of Cervical Cancer With Human Papillomavirus Tests
Franco, E. L. (2003) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003488 · Cited by 146
“Cuzick (4) 75 46 96 96 Clavel (5) 100 79 86 96 Recalculated for enrollment screening results Cuzick ( 6 ) 95 79 94 99 HPV indices based on HCII (n 1703) 76 95 HPV indices based on PCR (n 2988)”
BackgroundSankaranarayanan, R., Chatterji, R., Shastri, S. S., Wesley, R. S., Basu, P., Mahe, C., Muwonge, R., Seigneurin, D., Somanathan, T., Roy, C., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20396 · Cited by 127
Strander, B., Hallgren, J., & Sparen, P. (2014) · BMJ · doi:10.1136/bmj.f7361 · Cited by 98
Cost-effectiveness of primary HPV screening for cervical cancer in Germany—a decision analysis
Sroczynski, G., Schnell-Inderst, P., Mühlberger, N., Lang, K., Aidelsburger, P., Wasem, J., Mittendorf, T., Engel, J., Hillemanns, P., Petry, K. U., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.006 · Cited by 40
Estrade, C., Menoud, P.-A., Nardelli-Haefliger, D., & Sahli, R. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05039-11 · Cited by 40
Metadata
- Authors
- Cuzick, J., Beverley, E., Ho, L., Terry, G., Sapper, H., Mielzynska, I., Lorincz, A., Chan, W.-K., Krausz, T., & Soutter, P.
- Venue
- British Journal of Cancer
- Published
- 1999-09-10
- Volume
- 81
- Issue
- 3
- Pages
- 554-558
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2087659731
- Cited by
- 268
- References
- 17
- FWCI
- 15.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.